Lam Research (NASDAQ:LRCX) Price Target Raised to $158.00 at Morgan Stanley

Lam Research (NASDAQ:LRCX) had its target price lifted by Morgan Stanley from $137.00 to $158.00 in a research report report published on Tuesday, Marketbeat.com reports. The firm currently has an equal weight rating on the semiconductor company’s stock.

A number of other research analysts have also weighed in on LRCX. Susquehanna raised their target price on shares of Lam Research from $135.00 to $200.00 and gave the company a “positive” rating in a report on Thursday, October 23rd. Stifel Nicolaus set a $160.00 price objective on shares of Lam Research and gave the company a “buy” rating in a research report on Thursday, October 23rd. Weiss Ratings restated a “buy (b)” rating on shares of Lam Research in a report on Monday, November 24th. Wall Street Zen cut shares of Lam Research from a “buy” rating to a “hold” rating in a research report on Saturday, November 8th. Finally, Dbs Bank lifted their price target on Lam Research from $119.40 to $184.20 in a research report on Monday, October 27th. Twenty-six research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the stock. According to data from MarketBeat, Lam Research presently has a consensus rating of “Moderate Buy” and a consensus price target of $152.87.

Lam Research Stock Performance

Shares of NASDAQ LRCX opened at $158.19 on Tuesday. The company has a market cap of $198.69 billion, a P/E ratio of 34.84, a P/E/G ratio of 1.68 and a beta of 1.77. Lam Research has a 52-week low of $56.32 and a 52-week high of $167.15. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.60 and a current ratio of 2.21. The firm’s fifty day moving average is $148.20 and its two-hundred day moving average is $116.01.

Lam Research (NASDAQ:LRCX) last released its quarterly earnings data on Wednesday, October 22nd. The semiconductor company reported $1.26 EPS for the quarter, beating the consensus estimate of $1.22 by $0.04. Lam Research had a net margin of 29.66% and a return on equity of 60.60%. The business had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.23 billion. During the same quarter in the prior year, the firm earned $0.86 EPS. The business’s revenue was up 27.7% on a year-over-year basis. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. As a group, analysts anticipate that Lam Research will post 3.71 EPS for the current fiscal year.

Lam Research Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, January 7th. Stockholders of record on Wednesday, December 3rd will be issued a $0.26 dividend. This represents a $1.04 annualized dividend and a dividend yield of 0.7%. The ex-dividend date is Wednesday, December 3rd. Lam Research’s dividend payout ratio is presently 22.91%.

Insiders Place Their Bets

In other Lam Research news, Director Bethany Mayer sold 1,298 shares of the stock in a transaction on Monday, November 3rd. The stock was sold at an average price of $159.99, for a total value of $207,667.02. Following the sale, the director owned 1,652 shares in the company, valued at $264,303.48. This trade represents a 44.00% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Douglas R. Bettinger sold 40,080 shares of the business’s stock in a transaction on Friday, November 14th. The shares were sold at an average price of $150.60, for a total transaction of $6,036,048.00. Following the sale, the chief financial officer directly owned 987,237 shares of the company’s stock, valued at $148,677,892.20. This represents a 3.90% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 102,608 shares of company stock valued at $14,916,496 over the last quarter. 0.31% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in the stock. Stance Capital LLC purchased a new position in Lam Research during the 3rd quarter worth $26,000. Triumph Capital Management purchased a new position in shares of Lam Research during the third quarter valued at $27,000. IMG Wealth Management Inc. bought a new stake in shares of Lam Research in the second quarter valued at about $26,000. Howard Hughes Medical Institute bought a new stake in shares of Lam Research in the 2nd quarter valued at about $27,000. Finally, Sound Income Strategies LLC bought a new position in shares of Lam Research during the third quarter valued at approximately $41,000. Hedge funds and other institutional investors own 84.61% of the company’s stock.

Lam Research Company Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.